Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tanya A. Pinder
Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-Kinase Inhibitor Prodrug
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Related publications
Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cloning of a Novel Phosphatidylinositol Kinase-Related Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
Clinical Cancer Research
Cancer Research
Oncology
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Characterization of the Met326Ile Variant of Phosphatidylinositol 3-Kinase P85
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Treatment of Multiple Myeloma With VLA4-targeted Nanoparticles Delivering Novel C-Myc Inhibitor Prodrug
Phosphatidylinositol-3-Kinase Pathway
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-B-D-Arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma
Mouse P170 Is a Novel Phosphatidylinositol 3-Kinase Containing a C2 Domain
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
